Skip to content

NovoCure NVCR Shares (Basic)

Shares (Basic) at other companies

Boston Scientific logo
Boston ScientificBSX
1.5B+0.5%
Medtronic logo
MedtronicMDT
1.3B-0.3%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
418.5M+29.6%
Nuvation Bio logo
Nuvation BioNUVB
347.3M+2.6%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
88.3M+2.4%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
45.1M+32.9%

Other financials

Income statement

See full
Revenue$174.1M+12.3%
Gross profit$135.1M+16.0%
Operating income-$67.4M-78.1%
Net income-$71.1M-107%
EPS (diluted)-$0.62-100%

Balance sheet

See full
Cash & equivalents$87.5M-31.2%
Total debt$39.5M-2.1%
Total equity$330.7M-8.6%
Total assets$787.9M-36.9%

Cash flow

See full
Operating cash flow-$13.5M+62.1%
CapEx$5.2M-51.4%
Free cash flow-$18.7M+59.7%

Valuation

See full
Market cap$1.7B-36.7%
Enterprise value$1.66B-36.3%
P/S2.5×-1.8×

Profitability

See full
Gross margin75.2%-2.0pp
Operating margin-27.2%+0.4pp
Net margin-25.7%-0.7pp
FCF margin-7.1%-2.0pp

Returns & leverage

See full
Return on equity-50%+5.4pp
Debt / equity0.1×0.0×
Current ratio2.9×+1.4×

Where this comes from

Reported directly by NovoCure in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NovoCure's shares (basic)?
NovoCure (NVCR) reported shares (basic) of 114.1M in Q1 2026.
How has NovoCure's shares (basic) changed year-over-year?
NovoCure's shares (basic) increased by 3.5% year-over-year, from 110.3M to 114.1M.
What is the long-term trend for NovoCure's shares (basic)?
Over 4 years (2021 to 2025), NovoCure's shares (basic) has grown at a 1.9% compound annual growth rate (CAGR), from 413.7M to 445.2M.
What does shares (basic) mean?
The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.